Jamie Christensen Mirati Therapeutics, Inc. (MRTX) insider trading activity

Jamie Christensen is EVP & Chief Scientific Officer of Mirati Therapeutics, Inc.. Currently has a direct ownership of 0 shares of MRTX, which is worth approximately $0. The most recent transaction as insider was on Jan 23, 2024, when has been sold 154,996 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

100.0% 12M change

Total Value Held $0

Jamie Christensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 23 2024	SELL Sale (or disposition) back to the issuer	-	154,996 Reduced 100.0%	0 Common Stock
Jan 16 2024	SELL Open market or private sale	$94,254 $59.02 p/Share	1,597 Reduced 1.01%	155,927 Common Stock
Jan 04 2024	SELL Open market or private sale	$90,038 $58.81 p/Share	1,531 Reduced 0.96%	157,135 Common Stock
Dec 29 2023	BUY Grant, award, or other acquisition	$999,983 $58.75 p/Share	17,021 Added 9.69%	158,666 Common Stock
Dec 18 2023	SELL Open market or private sale	$137,252 $57.5 p/Share	2,387 Reduced 1.66%	141,645 Common Stock
Sep 08 2023	SELL Open market or private sale	$85,084 $35.63 p/Share	2,388 Reduced 1.63%	144,032 Common Stock
Aug 09 2023	BUY Grant, award, or other acquisition	$824,989 $37.0 p/Share	22,297 Added 13.22%	146,420 Common Stock
May 24 2023	SELL Open market or private sale	$28,034 $45.29 p/Share	619 Reduced 0.5%	124,123 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	26,864 Added 17.72%	124,742 Common Stock
Jan 17 2023	SELL Open market or private sale	$95,143 $42.38 p/Share	2,245 Reduced 2.24%	97,878 Common Stock
Jan 04 2023	SELL Open market or private sale	$90,823 $46.6 p/Share	1,949 Reduced 1.91%	100,123 Common Stock
Dec 16 2022	SELL Open market or private sale	$103,630 $43.0 p/Share	2,410 Reduced 2.31%	102,072 Common Stock
Dec 02 2022	SELL Open market or private sale	$155,667 $90.19 p/Share	1,726 Reduced 1.63%	104,482 Common Stock
Sep 07 2022	BUY Grant, award, or other acquisition	-	19,149 Added 15.29%	106,089 Common Stock
May 23 2022	SELL Open market or private sale	$39,649 $63.54 p/Share	624 Reduced 0.71%	86,804 Common Stock
Jan 18 2022	SELL Open market or private sale	$75,560 $120.51 p/Share	627 Reduced 0.71%	87,428 Common Stock
Jan 14 2022	BUY Grant, award, or other acquisition	-	10,755 Added 10.88%	88,055 Common Stock
Jan 04 2022	SELL Open market or private sale	$213,012 $147.72 p/Share	1,442 Reduced 1.83%	77,300 Common Stock
Dec 16 2021	BUY Grant, award, or other acquisition	-	19,149 Added 19.56%	78,742 Common Stock
Dec 06 2021	SELL Open market or private sale	$157,799 $131.39 p/Share	1,201 Reduced 1.98%	59,505 Common Stock
Dec 03 2021	BUY Grant, award, or other acquisition	-	6,856 Added 10.15%	60,706 Common Stock
May 24 2021	SELL Open market or private sale	$67,138 $154.34 p/Share	435 Reduced 0.8%	53,850 Common Stock
Jan 15 2021	BUY Grant, award, or other acquisition	-	7,023 Added 11.46%	54,285 Common Stock
Jan 06 2021	SELL Open market or private sale	$310,869 $213.07 p/Share	1,459 Reduced 2.99%	47,262 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$130,113 $11.96 p/Share	10,879 Added 18.25%	48,721 Common Stock

Jamie Christensen

EVP & Chief Scientific Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Mirati Therapeutics, Inc. insider buys or sells MRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Mirati Therapeutics, Inc.

Track Activities on MRTX

Account